This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Second Sight Medical Products Past Earnings Performance
Past criteria checks 0/6
Key information
24.9%
Earnings growth rate
48.2%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | -53.9% |
| Return on equity | -14.4% |
| Net Margin | n/a |
| Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
No updates
Recent updates
Second Sight, Nano Precision complete merger, renaming as Vivani Medical
Aug 30Second Sight Medical sheds ~17% after reverse stock split
Aug 19Second Sight stock rises as shareholders approve merger, name change, reverse stock split
Jul 29Second Sight stock rises ~10% on $1.1M funding from NIH for artificial vision implant trial
Jul 18Revisiting Second Sight Medical Products: The EV Is Negative And Being Short No Longer Looks Appealing
Mar 22Second Sight Medical rises defying legal battle; regains NASDAQ compliance
Jun 04Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Second Sight Medical Products makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 0 | -9 | 6 | 3 |
| 31 Mar 22 | 0 | -8 | 5 | 3 |
| 31 Dec 21 | 0 | -9 | 6 | 3 |
| 30 Sep 21 | 0 | -9 | 7 | 3 |
| 30 Jun 21 | 0 | -8 | 6 | 2 |
| 31 Mar 21 | 0 | -9 | 6 | 2 |
| 31 Dec 20 | 0 | -15 | 7 | 7 |
| 30 Sep 20 | 0 | -21 | 9 | 11 |
| 30 Jun 20 | 1 | -27 | 11 | 15 |
| 31 Mar 20 | 2 | -33 | 13 | 18 |
| 31 Dec 19 | 3 | -34 | 15 | 16 |
| 30 Sep 19 | 5 | -35 | 17 | 15 |
| 30 Jun 19 | 6 | -36 | 19 | 14 |
| 31 Mar 19 | 7 | -35 | 20 | 14 |
| 31 Dec 18 | 7 | -35 | 22 | 15 |
| 30 Sep 18 | 8 | -34 | 22 | 14 |
| 30 Jun 18 | 8 | -32 | 22 | 13 |
| 31 Mar 18 | 8 | -31 | 22 | 12 |
| 31 Dec 17 | 8 | -29 | 21 | 11 |
| 30 Sep 17 | 6 | -31 | 20 | 10 |
| 30 Jun 17 | 5 | -33 | 20 | 10 |
| 31 Mar 17 | 4 | -35 | 20 | 9 |
| 31 Dec 16 | 4 | -33 | 19 | 8 |
| 30 Sep 16 | 6 | -28 | 19 | 7 |
| 30 Jun 16 | 7 | -24 | 18 | 6 |
| 31 Mar 16 | 8 | -21 | 18 | 6 |
| 31 Dec 15 | 9 | -20 | 17 | 7 |
| 30 Sep 15 | 8 | -28 | 16 | 7 |
Quality Earnings: EYES is currently unprofitable.
Growing Profit Margin: EYES is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EYES is unprofitable, but has reduced losses over the past 5 years at a rate of 24.9% per year.
Accelerating Growth: Unable to compare EYES's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EYES is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (0.6%).
Return on Equity
High ROE: EYES has a negative Return on Equity (-14.39%), as it is currently unprofitable.